Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Article in English | IMSEAR | ID: sea-137447

ABSTRACT

The purpose of this quasi-experimental research was to study effects of kangaroo Care on skin temperature, rectal temperature, body weight, and maternal satisfaction. Samples were 30 premature infants with post-conceptional age between 33-35 weeks, appropriate for gestational age, post-birth for 1 week, and without complications. The infant was randomly assigned to experimental and cotrol roup. Infants in both groups were mateched according to post-comceptional age, body weight, and calory intake. Infants in experimental group received Kangaroo Care from their mothers twice a day, for a period of 45-60 minutes each time. Infants in control group received routine care from nurses in the unit. The results revealed that the mean skin temperature and rectal temperature of the experimental roup after Kangaroo Care wre significantly higher than before kangaroo Care. The mean body weight of infants in both gorups was not significantly different. The mean score of maternal satisfaction in experimental group was significantly higher than control group. Recommendation from the study is that Kangaroo Care will maintan body temperature and promote maternal-infant attachment.

2.
Article in English | IMSEAR | ID: sea-138449

ABSTRACT

Thirteen critically ill infants received tolazoline because of sever hypoxaemia refractory to administration of 100 percent oxygen and mechanical ventilation (in 12 infants). Six (46.15%) responded with a mean increase in PaO2 of 151.32 torr within one hour after starting tolazoline. Only 4 of these receiving tolazaline could have the treatment stopped when oxygen requirement was 60 percent without recurrent hypoxaemia. The survival in the responders was 83 percent. Seven patients had little or no improvement in PaO2 following tolazoline and only 3 (42%) of these infants survived. The overall survival was 61 percent. All infants experienced complications possibly related to tolazoline.

SELECTION OF CITATIONS
SEARCH DETAIL